The TRIUMPH-2 and SYNCHRONIZE-2 studies show both novel agents to be highly effective, but some questions remain.

BARCELONA, Spain—The DEDICATE-DZHK6 trial comparing TAVI with SAVR in low-to-intermediate-risk German patients with aortic ...

The expert consensus decision pathway goes beyond the guidelines to provide practice advice around BP management.

A postapproval study and a subgroup analysis of complex patients show high efficacy rates for the two limus-eluting ...

This year marks the 40th anniversary of the cardiothoracic surgery organization, and it has a big celebration planned. Receive the the latest news, research, and presentations from major meetings ...

From PAD to pulmonary embolism and stroke, the meeting promises to be packed with cutting-edge vascular therapy news.

Observational studies from Spain, Italy, and the United States help paint a clearer picture of a growing field.

The observational Swedish data need to be further explored but may have identified a new screening target in stroke ...

This year marks the 40th anniversary of the cardiothoracic surgery organization, and it has a big celebration planned.

Two new observational studies add to the growing evidence base on cardiovascular risks associated with hormone replacement ...

A retrospective analysis shows that when CMR and FDG PET/CT findings are concordant, patients are more vulnerable to events.

The evolving data now show clear biological efficacy with impact on hard clinical outcomes, says Sahil Parikh.